Skip to main content

Memberships from $89/mo — Rookie IV, shots, Fire & Ice & more

Join Now
I.V. League Hydration

IV League Blog

Semaglutide vs Tirzepatide: Which Works Better?

Published August 2, 2026·Weight Loss, Semaglutide, Tirzepatide, GLP-1, Boston
Semaglutide vs Tirzepatide: Which Works Better?

Semaglutide and tirzepatide are the two most effective weight-loss medications available today, but they are not the same drug. Semaglutide (the molecule in Ozempic and Wegovy) works on one hormone pathway. Tirzepatide (Mounjaro, Zepbound) works on two. That single difference explains most of the gap in results, side effects and price.

Here is the head-to-head comparison our nurse practitioners give patients at IV League Hydration in South Boston.

What is the difference between semaglutide and tirzepatide?

Semaglutide is a GLP-1 receptor agonist. It mimics glucagon-like peptide-1, a gut hormone that slows stomach emptying, signals fullness to the brain and improves insulin response.

Tirzepatide is a dual GLP-1 and GIP receptor agonist. It does everything semaglutide does, and it also activates GIP (glucose-dependent insulinotropic polypeptide), a second incretin hormone that appears to improve how the body stores and burns fat and may blunt nausea.

Both are weekly subcutaneous injections. Both require a prescription and medical supervision. Learn more about how these peptides work on our semaglutide and tirzepatide pages.

Which is better for weight loss, semaglutide or tirzepatide?

On average weight loss, tirzepatide wins. In the pivotal trials:

  • Semaglutide 2.4 mg (STEP 1): about 15% average body-weight loss at 68 weeks.
  • Tirzepatide 15 mg (SURMOUNT-1): about 21% average body-weight loss at 72 weeks.
  • Head-to-head (SURMOUNT-5): tirzepatide produced roughly 20% loss versus about 14% for semaglutide over 72 weeks.

That said, "better on average" is not "better for you." Plenty of patients hit their goal on semaglutide at a lower dose, lower cost and with fewer GI symptoms. Starting on semaglutide and switching later is a completely reasonable plan.

What are the side effects of semaglutide vs tirzepatide?

The side-effect profiles are very similar because both act on GLP-1. The most common are nausea, constipation, diarrhea, burping, fatigue and injection-site reactions, and they are worst in the first week after each dose increase.

Practical differences we see in clinic:

  • Nausea tends to be reported slightly less often with tirzepatide at comparable weight-loss levels, likely from the GIP effect.
  • Constipation is common on both and responds to fluids, fiber and magnesium.
  • Dehydration is the most under-appreciated issue on both drugs — eating and drinking less means electrolytes drop. Our IV hydration drips are the most common add-on our GLP-1 patients use.

Both carry a boxed warning for thyroid C-cell tumors seen in rodents and should not be used if you or a family member has medullary thyroid carcinoma or MEN2.

How much does semaglutide vs tirzepatide cost in Boston?

Brand-name Ozempic, Wegovy, Mounjaro and Zepbound run roughly $1,000–$1,400 per month without insurance coverage. Our medically supervised programs are flat-rate and include the medication, supplies, dose titration and NP follow-up:

  • Semaglutide program — $299/month
  • Tirzepatide program — $399/month
  • Buy your own vial — ask us for pricing (biggest savings, shipped directly to your door)

If you want the lowest cost per month, ask our NP about purchasing your own vial. We’ll size the vial to your titration plan and ship it straight to your door with syringes, dosing chart and NP oversight included.

No membership required, no hidden fees, and you can switch programs as you titrate. See the full breakdown on our weight loss injections page or compare with national telehealth pricing on our shipped-to-you hub.

Can you switch from semaglutide to tirzepatide?

Yes, and it is common. Patients typically switch when weight loss stalls for 8–12 weeks at a therapeutic semaglutide dose, or when side effects are not tolerable. Switching is not a one-to-one dose conversion — you restart tirzepatide at its lowest dose (2.5 mg) and titrate up, which usually means a brief plateau before losses resume. Always do this under a prescriber's supervision.

Do you lose muscle on semaglutide or tirzepatide?

Some lean-mass loss happens on both, and it is the single most important thing to protect. Aim for 1.0–1.2 g of protein per kg of goal body weight daily, lift two to three times a week, and keep hydration and B-vitamin status up. Our patients often pair their program with B12 injections and amino-acid-containing drips to support energy and recovery through the calorie deficit.

Which should I start with?

A simple rule of thumb we use:

  • Start semaglutide if you have 20–40 lb to lose, want the lower monthly cost, or are cautious about GI side effects.
  • Start tirzepatide if you have more than 40 lb to lose, have type 2 diabetes or significant insulin resistance, or have already plateaued on semaglutide.

Either way, the medication is one part of the plan. Protein, resistance training, sleep and hydration decide how good the result actually looks.

Start a GLP-1 program in South Boston

IV League Hydration has been running nurse-led wellness care in Boston since 2018. Our NPs handle the consult, labs review, prescription, dose titration and monthly check-ins at our A Street and L Street clinics — or shipped to your door.

Book a GLP-1 consult or take our two-minute quiz to see which program fits.

This article is educational and is not medical advice. Semaglutide and tirzepatide are prescription medications that require evaluation by a licensed provider.

IV therapy near you

Serving Greater Boston

Walk in at our two South Boston clinics, or book same-day mobile IV therapy to your home, hotel, or office in these neighborhoods:

Ready to book?

Talk to a real medical team in South Boston.

IV League Hydration has been Boston's trusted nurse-owned wellness clinic since 2018. Book online, see our full IV therapy pricing, walk in, or call 1-800-905-4252.